Skip to main content
Caplight Logo









Glyconics

Glyconics

Private
ColchesterHealthcare & Life Scienceshttps://glyconics.com/

Last Round

Seed

Nov 18, 2021

Total Funding Raised

$2.33M

Company Overview

Glyconics is a biotechnology company that develops spectroscopy-based diagnostic tools for the non-invasive detection and monitoring of respiratory diseases and diabetes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

point-of-care diagnosticsinfrared spectroscopynon-invasive testingmedical devicePOC diagnosticsbiomarker screeningchronic disease monitoringhandheld diagnostic devicedigital healthchemometricshealth techremote patient monitoringRPMmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Glyconics Comparables

Compare Glyconics with similar companies based on industry and business-model similarity.

Glyconics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
1Drop Diagnostics
81%
Nostics
79%
DiaMonTech AG
78%

Glyconics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 18, 2021
GrantOct 15, 2020
GrantFeb 19, 2018

Glyconics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 28, 2025

    Monthly visitors grew 34% MoM.

  • Nov 18, 2021

    $2M round led by Wealth Club.

Glyconics Filings

Explore SEC and related filing metadata, where available.

Glyconics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Glyconics's valuation, stock price, and market status.

Is Glyconics a public or private company?

Glyconics is a private company.

What is the current stock price of Glyconics?

Glyconics is a private company with no public stock price. Caplight tracks Glyconics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Glyconics worth (valuation)?

Valuation information for Glyconics is not publicly available.

Can I buy Glyconics stock?

Glyconics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Glyconics's last funding round?

Glyconics's most recent funding round was Seed on November 18, 2021.

Who are the main investors in Glyconics?

Key investors in Glyconics include Wealth Club.

Will Glyconics IPO soon?

No public IPO plans have been announced for Glyconics.

How can I track Glyconics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Glyconics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersColchester
Employee Range2
Year Founded2013
Last FundingNov 18, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?